Research cooperation within the bio-pharmaceutical industry: Network analyses of co-publications within and between firms
- 565 Downloads
Bio-pharmaceutical R&D is increasingly an international affair. Research articles published in the peer-reviewed international scientific and technical journals represent quantifiable research outputs of bio-pharmaceutical firms. Large-scale systemic measurements of worldwide trends and sectoral patterns within bio-pharmaceutical science can be gauged from these articles, where coauthored research papers are assumed to reflect research cooperation and associated knowledge flows and exchanges. We focus our attention on the largest science-based multinational enterprises (MNEs), those that produce relatively large quantities of research articles. The study deals with the worldwide output of research articles that are co-produced by corporate researchers during the years 1996–2001.
We employ these publications to examine structural factors characterizing research cooperation networks within industry at the level of major geographical regions (North America, Europe, Pacific-Asia), with a breakdown by within-MNE and between-MNE network linkages. The descriptive statistics on publication output and results of network analyses of co-publication linkages not only indicate regional differences, with a central role for US companies in biopharmaceutical research, but also a variety of firm-specific research cooperation networks which enabled us to develop a tentative typology of MNEs in terms of their intra- and interorganizational patterns of research cooperation linkages.
- Borgatti, S. P., Everett, M. G., Freeman, L. C. (2002), Ucinet 6 for Windows. Harvard: Analytic Technologies.Google Scholar
- Brusconi, S., Criscuolo, P., Geuna, A. (2005), The knowledge bases of the world’s largest biopharmaceuticals groups: what do the patent citations to non-patent literature reveal? Economics of Innovation and New Technology, 14: 395–415.Google Scholar
- Cantwell, J., Janne, O. (2000), The role of multinational corporations and national states in the globalization of innovatory capacity: the European perspective. Technology Analysis and Strategic Management, 12: 243–262.Google Scholar
- Criscuolo P., Narula, R. (2005), Using Multi-hub Structures for International R&D: Organizational Inertia and the Challenges of Implemetation, Working paper.Google Scholar
- EC (2003), Third European Report on Science and Technology Indicators: Towards a Knowledge-Based Economy. Brussels: European Commission, Report EUR 200025.Google Scholar
- Gambardella, A. (1995), Science and Innovation. The US Pharmaceutical Industry during the 1980s. Cambridge University Press, Cambridge.Google Scholar
- Henderson, R., Cockburn, I. (1994), Measuring competence? Exploring firm effects in pharmaceutical research. Strategic Management Journal, 15 (Winter): 63–84.Google Scholar
- Jaffe, A. (1989), Real effects of academic research. American Economic Review, 79: 957–970.Google Scholar
- Mowery, D. C., Oxley, J. E., Silverman, B. S. (1996), Strategic alliances and interfirm knowledge transfer. Strategic Management Journal, 17: 77–91.Google Scholar
- Tijssen, R. J. W., Van Leeuwen, Th. N., Korevaar, J. C. (1996), Scientific publication activity of industry in the Netherlands. Research Evaluation, 6: 1–15.Google Scholar